Health Discovery Corporation (HDVY)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 20, 2025
Health Discovery Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2011 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2011 - 2015 |
| Revenue | - | 0 | 1.52 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Revenue Growth (YoY) | - | -99.93% | 3328.89% | -1.45% | 3.31% | -2.44% | Upgrade
|
| Gross Profit | - | 0 | 1.52 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Selling, General & Admin | 2.18 | 1.37 | 1.29 | 0.55 | 0.64 | 0.71 | Upgrade
|
| Research & Development | - | - | - | - | - | 0.03 | Upgrade
|
| Operating Expenses | 2.18 | 1.37 | 1.44 | 0.81 | 0.9 | 1 | Upgrade
|
| Operating Income | -2.18 | -1.37 | 0.08 | -0.77 | -0.86 | -0.95 | Upgrade
|
| Interest Expense | -0.02 | -0.01 | -0.04 | -0.03 | -0 | - | Upgrade
|
| Interest & Investment Income | - | 0 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.99 | - | - | - | -1.2 | Upgrade
|
| EBT Excluding Unusual Items | -2.2 | -0.38 | 0.04 | -0.8 | -0.86 | -2.15 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | 0.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.01 | 0.01 | Upgrade
|
| Legal Settlements | -0.72 | -0.38 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 1.52 | - | - | - | Upgrade
|
| Pretax Income | -2.91 | -0.76 | 1.56 | -0.8 | -0.87 | -2.07 | Upgrade
|
| Net Income | -2.91 | -0.76 | 1.56 | -0.8 | -0.87 | -2.07 | Upgrade
|
| Net Income to Common | -2.91 | -0.76 | 1.56 | -0.8 | -0.87 | -2.07 | Upgrade
|
| Shares Outstanding (Basic) | 405 | 398 | 295 | 272 | 272 | 272 | Upgrade
|
| Shares Outstanding (Diluted) | 405 | 398 | 370 | 272 | 272 | 272 | Upgrade
|
| Shares Change (YoY) | 8.84% | 7.49% | 36.14% | - | - | 2.13% | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | 0.01 | -0.00 | -0.00 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | 0.00 | -0.00 | -0.00 | -0.01 | Upgrade
|
| Free Cash Flow | -1.24 | -1.38 | 2.2 | -0.28 | -0.31 | -0.47 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | -136700.00% | 5.20% | -1737.29% | -1912.30% | -2192.79% | Upgrade
|
| Profit Margin | - | -75900.00% | 102.77% | -1795.65% | -1944.09% | -4754.13% | Upgrade
|
| Free Cash Flow Margin | - | -137900.00% | 145.03% | -621.98% | -698.55% | -1070.87% | Upgrade
|
| EBITDA | - | -1.21 | 0.23 | -0.51 | -0.6 | -0.69 | Upgrade
|
| EBITDA Margin | - | - | 15.27% | - | - | - | Upgrade
|
| D&A For EBITDA | - | 0.15 | 0.15 | 0.26 | 0.26 | 0.26 | Upgrade
|
| EBIT | -2.18 | -1.37 | 0.08 | -0.77 | -0.86 | -0.95 | Upgrade
|
| EBIT Margin | - | - | 5.20% | - | - | - | Upgrade
|
| Revenue as Reported | 0 | 0 | 1.52 | 0.04 | 0.04 | 0.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.